Avalon Pharmaceuticals to Present at Biotechnology Industry Organization (BIO) Investor Forum 2007

GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), today announced that Kenneth C. Carter, Ph.D., President and CEO, is scheduled to provide an update on the Company at the Bio Investor Forum 2007. The conference will be held at The Palace Hotel in San Francisco, CA on October 9-11, 2007. Dr. Carter is scheduled to present on Thursday, October 11, at 11:00 am PDT.
MORE ON THIS TOPIC